$12.130
-0.050 (-0.41%)收盘时
价格预测
在 App 中打开以解锁更长周期的预测。
RDY 相似图表分析预测
Alphio's RDY stock price prediction model matches the current Dr Reddy's Laboratories Ltd tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $12.33 (+1.34%). The 1-week path is $12.62 (+3.66%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
该买入 Dr Reddy's Laboratories Ltd 股票吗?
Dr Reddy's Laboratories Ltd is not a good buy right now due to a recent downgrade from Goldman Sachs, which set a price target of INR 1,075, significantly lower than the current price of $12.18. Additionally, the company's last earnings report showed an EPS of 0.06, which was a 64.71% miss from the expected 0.17, indicating potential ongoing financial struggles. The RSI is currently at 47.072, suggesting the stock is neither overbought nor oversold, but the lack of upward momentum and negative analyst sentiment point to a sell recommendation.
RDY 股价于 Monday 收于 $12.13,此前下跌 -0.41%
Dr Reddy's Laboratories Ltd (RDY) last closed at $12.17, gaining +0.33%. These facts feed the 1-day and 1-week RDY price prediction above.
分析师一致预期
Dr Reddy's Laboratories Ltd(RDY):买入 0、持有 0、卖出 1。展望:Strong Sell。
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
预测驱动因素
Dr Reddy's Laboratories Ltd(RDY)的预测驱动因素综合了相似的图表形态、季节性与移动平均线。
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
相似图表形态
近期走势与 RDY 最接近的股票,按相似度排序。
RDY 季节性分析
Historically the probability of a positive September return for RDY is 47.62%. February offers the highest probability of a positive month at 63.79%, while January is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
本页仅供研究参考,不构成投资建议。模型可能出错。过往表现不代表未来结果。